Wednesday, September 02, 2020 3:58:04 PM
Your response .... isn't your usual positive self. Wassup ?
Thought you'd point out the positives in the update.
While again it is a yawner ......
16 trials for chickens goes to the absurdity of the testing being done. No end in sight.
I would love to hear someone ask Dahl what opportunities have been explored for ZIVO in the "low hanging fruit" department. Ya know, those that don't require 30 trials and 10 years of testing. Immune enhancement nutraceutical .... hmmm ... Proalgazyme anyone ? Anyone ? Echoooo ... echooooooooooo ......
If I'm understanding Dahl speak (told him before ... need 5th grader to understand) the complex might be reproduced separate from the algae now ?
Mastitis ... more analysis .... at this point again .... ZIVO needs to get something on the books and if Zoetis isn't coming to the table anytime soon ... WHAT'S THE POINT OF CONTINUING WITHOUT REVENUE COMING FROM SOMEWHERE TO OFFSET THE TIME AND COST.
Nutriquest Europe ... some day
Poutry GRAS .... ZIVO's biggest opportunity on hold .... wow ... can't produce ... claimed to be nearest potential revenue generator .... doesn't make sense.
Skin topical ingredient ... sounds like that should take priority if can be offered as ingredient quickly.
Production ... Grupo Alimenta is no joke and aims to get chit done for a sustainable future. Has gotten millions to build and produce spiralina already.
A company in Mexico negotiating to build a production facility at own expense and license everything ..... why would they do that ?? They think they can sell it I'd have to assume. Groundbreaking mid September (assume 2020 LOL) should have a PR any day on it. ZIVO a buyer for all its customers eh ? What customers ?
New Doc in the fold. One thing funny of note .... if one were to peruse the Algenol website ... main page .... LOL .... shows someone rubbing a lotion on their hand .... shows a woman doing a facial .... shows a mason jar with handle filled with what would be a veggie drink no doubt containing algae ..... hmmmmm ... where have I heard all that before ????
Ya see .... all this has been done already ..... while ZIVO spouts ... pending funding ....
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM